Nice hypothesis. Two issues.
Firstly, Wolgen has been as emphatic as humanly possible that with him in charge afamelanotide WILL NEVER be used for a cosmetic tan.
Secondly, Clinuvel over the last 5 years have reinterpreted the under promise over deliver mantra to under promise and then even with incredibly low expectations fail to meet them and set a new standard in under delivery.
How’s that vitiligo trial going? Wouldn’t mind an update.
- Forums
- ASX - By Stock
- CUV
- Ann: Syd Capital Markets Briefing Presentation
Ann: Syd Capital Markets Briefing Presentation, page-73
-
- There are more pages in this discussion • 18 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add CUV (ASX) to my watchlist
|
|||||
Last
$13.37 |
Change
0.180(1.36%) |
Mkt cap ! $669.5M |
Open | High | Low | Value | Volume |
$13.19 | $13.59 | $13.13 | $1.181M | 88.20K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 606 | $13.31 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$13.51 | 282 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 606 | 13.310 |
4 | 8584 | 13.300 |
1 | 282 | 13.280 |
1 | 948 | 13.270 |
1 | 282 | 13.260 |
Price($) | Vol. | No. |
---|---|---|
13.510 | 282 | 1 |
13.530 | 1865 | 4 |
13.550 | 282 | 1 |
13.580 | 282 | 1 |
13.600 | 1448 | 2 |
Last trade - 16.10pm 23/08/2024 (20 minute delay) ? |
Featured News
CUV (ASX) Chart |
The Watchlist
SER
STRATEGIC ENERGY RESOURCES LIMITED
David DeTata, Managing Director
David DeTata
Managing Director
SPONSORED BY The Market Online